Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET).


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
04 05 2021
Historique:
received: 01 06 2020
accepted: 14 07 2020
pubmed: 17 7 2020
medline: 11 5 2021
entrez: 17 7 2020
Statut: ppublish

Résumé

Currently, the United States has the largest number of reported coronavirus disease 2019 (COVID-19) cases and deaths globally. Using a geographically diverse surveillance network, we describe risk factors for severe outcomes among adults hospitalized with COVID-19. We analyzed data from 2491 adults hospitalized with laboratory-confirmed COVID-19 between 1 March-2 May 2020, as identified through the Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, which comprises 154 acute-care hospitals in 74 counties in 13 states. We used multivariable analyses to assess associations between age, sex, race and ethnicity, and underlying conditions with intensive care unit (ICU) admission and in-hospital mortality. The data show that 92% of patients had ≥1 underlying condition; 32% required ICU admission; 19% required invasive mechanical ventilation; and 17% died. Independent factors associated with ICU admission included ages 50-64, 65-74, 75-84, and ≥85 years versus 18-39 years (adjusted risk ratios [aRRs], 1.53, 1.65, 1.84, and 1.43, respectively); male sex (aRR, 1.34); obesity (aRR, 1.31); immunosuppression (aRR, 1.29); and diabetes (aRR, 1.13). Independent factors associated with in-hospital mortality included ages 50-64, 65-74, 75-84, and ≥ 85 years versus 18-39 years (aRRs, 3.11, 5.77, 7.67, and 10.98, respectively); male sex (aRR, 1.30); immunosuppression (aRR, 1.39); renal disease (aRR, 1.33); chronic lung disease (aRR 1.31); cardiovascular disease (aRR, 1.28); neurologic disorders (aRR, 1.25); and diabetes (aRR, 1.19). In-hospital mortality increased markedly with increasing age. Aggressive implementation of prevention strategies, including social distancing and rigorous hand hygiene, may benefit the population as a whole, as well as those at highest risk for COVID-19-related complications.

Sections du résumé

BACKGROUND
Currently, the United States has the largest number of reported coronavirus disease 2019 (COVID-19) cases and deaths globally. Using a geographically diverse surveillance network, we describe risk factors for severe outcomes among adults hospitalized with COVID-19.
METHODS
We analyzed data from 2491 adults hospitalized with laboratory-confirmed COVID-19 between 1 March-2 May 2020, as identified through the Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, which comprises 154 acute-care hospitals in 74 counties in 13 states. We used multivariable analyses to assess associations between age, sex, race and ethnicity, and underlying conditions with intensive care unit (ICU) admission and in-hospital mortality.
RESULTS
The data show that 92% of patients had ≥1 underlying condition; 32% required ICU admission; 19% required invasive mechanical ventilation; and 17% died. Independent factors associated with ICU admission included ages 50-64, 65-74, 75-84, and ≥85 years versus 18-39 years (adjusted risk ratios [aRRs], 1.53, 1.65, 1.84, and 1.43, respectively); male sex (aRR, 1.34); obesity (aRR, 1.31); immunosuppression (aRR, 1.29); and diabetes (aRR, 1.13). Independent factors associated with in-hospital mortality included ages 50-64, 65-74, 75-84, and ≥ 85 years versus 18-39 years (aRRs, 3.11, 5.77, 7.67, and 10.98, respectively); male sex (aRR, 1.30); immunosuppression (aRR, 1.39); renal disease (aRR, 1.33); chronic lung disease (aRR 1.31); cardiovascular disease (aRR, 1.28); neurologic disorders (aRR, 1.25); and diabetes (aRR, 1.19).
CONCLUSIONS
In-hospital mortality increased markedly with increasing age. Aggressive implementation of prevention strategies, including social distancing and rigorous hand hygiene, may benefit the population as a whole, as well as those at highest risk for COVID-19-related complications.

Identifiants

pubmed: 32674114
pii: 5872581
doi: 10.1093/cid/ciaa1012
pmc: PMC7454425
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e206-e214

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Auteurs

Lindsay Kim (L)

Coronavirus Disease 2019 (COVID-19) Associated Hospitalization Surveillance Network (COVID-NET) Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
US Public Health Service, Rockville, Maryland, USA.

Shikha Garg (S)

Coronavirus Disease 2019 (COVID-19) Associated Hospitalization Surveillance Network (COVID-NET) Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
US Public Health Service, Rockville, Maryland, USA.

Alissa O'Halloran (A)

Coronavirus Disease 2019 (COVID-19) Associated Hospitalization Surveillance Network (COVID-NET) Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Michael Whitaker (M)

Coronavirus Disease 2019 (COVID-19) Associated Hospitalization Surveillance Network (COVID-NET) Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Eagle Global Scientific, Atlanta, Georgia, USA.

Huong Pham (H)

Coronavirus Disease 2019 (COVID-19) Associated Hospitalization Surveillance Network (COVID-NET) Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Evan J Anderson (EJ)

Department of Medicine and Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Emerging Infections Program, Georgia Department of Health, Atlanta, Georgia, USA.
Veterans Affairs Medical Center, Atlanta, Georgia, USA.

Isaac Armistead (I)

University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Nancy M Bennett (NM)

University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.

Laurie Billing (L)

Ohio Department of Health, Columbus, Ohio, USA.

Kathryn Como-Sabetti (K)

Minnesota Department of Health, St. Paul, Minnesota, USA.

Mary Hill (M)

Salt Lake County Health Department, Salt Lake City, Utah, USA.

Sue Kim (S)

Michigan Department of Health and Human Services, Lansing, Michigan, USA.

Maya L Monroe (ML)

Maryland Department of Health, Baltimore, Maryland, USA.

Alison Muse (A)

New York State Department of Health, Albany, New York, USA.

Arthur L Reingold (AL)

University of California, Berkeley, Berkeley, California, USA.

William Schaffner (W)

Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Melissa Sutton (M)

Oregon Health Authority, Portland, Oregon, USA.

H Keipp Talbot (HK)

Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Salina M Torres (SM)

New Mexico Department of Health, Santa Fe, New Mexico, USA.

Kimberly Yousey-Hindes (K)

Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA.

Rachel Holstein (R)

Coronavirus Disease 2019 (COVID-19) Associated Hospitalization Surveillance Network (COVID-NET) Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.

Charisse Cummings (C)

Coronavirus Disease 2019 (COVID-19) Associated Hospitalization Surveillance Network (COVID-NET) Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Chickasaw Nation Industries, Norman, Oklahoma, USA.

Lynnette Brammer (L)

Coronavirus Disease 2019 (COVID-19) Associated Hospitalization Surveillance Network (COVID-NET) Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Aron J Hall (AJ)

Coronavirus Disease 2019 (COVID-19) Associated Hospitalization Surveillance Network (COVID-NET) Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Alicia M Fry (AM)

Coronavirus Disease 2019 (COVID-19) Associated Hospitalization Surveillance Network (COVID-NET) Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Gayle E Langley (GE)

Coronavirus Disease 2019 (COVID-19) Associated Hospitalization Surveillance Network (COVID-NET) Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH